Identifying glioblastoma margins using dual-targeted organic nanoparticles for efficient in vivo fluorescence image-guided photothermal therapy
Source abstract
Abstract
Dual-targeted organic nanoparticles efficiently target the margin of glioblastoma and successfully suppress the tumour growth through photothermal therapy.
Only a short abstract or summary was supplied by the source.
Source: crossref · Quality: short
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biomolecular Engineering
National University of Singapore
Singapore 117585
Singapore
Singapore Institute for Neurotechnology (SINAPSE)
Singapore 117456
Institute of Biomedical Engineering and Nanomedicine
Departments of Biochemistry and Physiology
Yong Loo Lin School of Medicine
Funding
National Research Foundation Singapore · National University of Singapore
References (34)
Show source-provided references
1. Roy · South Asian J. Cancer · 2015 · 4 · 16310.4103/2278-330X.175953 ↗
2. Holland · Proc. Natl. Acad. Sci. U. S. A. · 2000 · 97 · 624210.1073/pnas.97.12.6242 ↗
3. Young · Ann. Transl. Med. · 2015 · 3 · 121
4. Krex · Brain · 2007 · 130 · 259610.1093/brain/awm204 ↗
5. Scott · Ann. Neurol. · 1999 · 46 · 18310.1002/1531-8249(199908)46:2<183::AID-ANA7>3.0.CO;2-7 ↗
6. Robins · Curr. Oncol. Rep. · 2007 · 9 · 6610.1007/BF02951428 ↗
7. Khosla · Ann. Transl. Med. · 2016 · 4 · 5410.21037/atm.2016.10.07 ↗
8. Guo · Exp. Cell Res. · 2014 · 320 · 20010.1016/j.yexcr.2013.10.020 ↗
9. Stupp · Lancet Oncol. · 2009 · 10 · 45910.1016/S1470-2045(09)70025-7 ↗
10. Carlsson · EMBO Mol. Med. · 2014 · 6 · 135910.15252/emmm.201302627 ↗
11. Lilja · J. Comput. Assist. Tomogr. · 1981 · 5 · 62510.1016/0149-936X(81)90093-X ↗
12. Kelly · J. Neurosurg. · 1987 · 66 · 86510.3171/jns.1987.66.6.0865 ↗
13. Lunsford · Acta Radiol., Suppl. · 1986 · 369 · 154
14. Ishihara · J. Neuropathol. Exp. Neurol. · 2008 · 67 · 43510.1097/NEN.0b013e31816fd622 ↗
15. Gu · Front. Biosci. · 2011 · 3 · 121610.2741/222 ↗
16. Karathanasis · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2016 · 8 · 678
17. Dubois · Front. Cell. Neurosci. · 2014 · 8 · 41810.3389/fncel.2014.00418 ↗
18. van Tellingen · Drug Resist. Updat. · 2015 · 19 · 110.1016/j.drup.2015.02.002 ↗
19. Song · Drug Deliv. · 2016 · 23 · 140410.3109/10717544.2015.1064186 ↗
20. Mangraviti · ACS Nano · 2015 · 9 · 123610.1021/nn504905q ↗
21. Munoz · Mol. Ther. Nucleic Acids · 2013 · 2 · e12610.1038/mtna.2013.60 ↗
22. Rodriguez · Pharmaceutics · 2015 · 7 · 17510.3390/pharmaceutics7030175 ↗
23. Gabathuler · Neurobiol. Dis. · 2010 · 37 · 4810.1016/j.nbd.2009.07.028 ↗
24. Zou · Theranostics · 2016 · 6 · 76210.7150/thno.14988 ↗
25. Abadeer · J. Phys. Chem. C · 2016 · 120 · 469110.1021/acs.jpcc.5b11232 ↗
26. Cai · Adv. Mater. · 2016 · 28 · 876010.1002/adma.201601191 ↗
27. Lu · Cancer Res. · 2011 · 71 · 611610.1158/0008-5472.CAN-10-4557 ↗
28. Baek · J. Neurooncol. · 2011 · 104 · 43910.1007/s11060-010-0511-3 ↗
29. Yang · Nano Lett. · 2010 · 10 · 331810.1021/nl100996u ↗
30. Wang · J. Am. Chem. Soc. · 2013 · 135 · 479910.1021/ja312221g ↗
31. Xu · Int. J. Pharm. · 2012 · 426 · 18210.1016/j.ijpharm.2012.01.009 ↗
32. Srivatsan · Mol. Pharm. · 2011 · 8 · 118610.1021/mp200018y ↗
33. Oller-Salvia · Chem. Soc. Rev. · 2016 · 45 · 469010.1039/C6CS00076B ↗
34. Lapchak · PLoS One · 2015 · 10 · e012758010.1371/journal.pone.0127580 ↗